MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin

Accumulating data have shown the involvement of microRNAs in cancerous processes as either oncogenes or tumor suppressor genes. Here, we established miR-30a as a tumor suppressor gene in breast cancer development and metastasis. Ectopic expression of miR-30a in breast cancer cell lines resulted in the suppression of cell growth and metastasis in vitro. Consistently, the xenograft mouse model also unveiled the suppressive effects of miR-30a on tumor growth and distal pulmonary metastasis. With dual luciferase reporter assay, we revealed that miR-30a could bind to the 3′-untranslated region of metadherin (MTDH) gene, thus exerting inhibitory effect on MTDH. Furthermore, we demonstrated that silence of MTDH could recapitulate the effects of miR-30a overexpression, while overexpression of MTDH could partially abrogate miR-30a-mediated suppression. Of significance, expression level of miR-30a was found to be significantly lower in primary breast cancer tissues than in the paired normal tissues. Further evaluation verified that miR-30a was negatively correlated with the extent of lymph node and lung metastasis in patients with breast cancer. Taken together, our findings indicated miR-30a inhibits breast cancer proliferation and metastasis by directly targeting MTDH, and miR-30a can serve as a prognostic marker for breast cancer. Manipulation of miR-30a may provide a promising therapeutic strategy for breast cancer treatment.

[1]  Guixing Xu,et al.  Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas , 2010, Clinical Neurology and Neurosurgery.

[2]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[3]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[4]  C. Theillet,et al.  Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Yibin Kang,et al.  The Multifaceted Role of MTDH/AEG-1 in Cancer Progression , 2009, Clinical Cancer Research.

[6]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[7]  Ning Zhang,et al.  Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis , 2010, Cancer science.

[8]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[9]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[10]  Sun Mi Park,et al.  MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death , 2008, Oncogene.

[11]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[12]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[13]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[14]  A. Luo,et al.  MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 , 2013, Oncogene.

[15]  Qifeng Yang,et al.  Inhibition of metadherin sensitizes breast cancer cells to AZD6244 , 2012, Cancer biology & therapy.

[16]  J. Steitz,et al.  miR-29 and miR-30 regulate B-Myb expression during cellular senescence , 2010, Proceedings of the National Academy of Sciences.

[17]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[18]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[19]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[20]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[21]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[23]  Y Pawitan,et al.  Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer , 2013, Oncogene.

[24]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[25]  Xiaolong Wang,et al.  The Oncogene Metadherin Modulates the Apoptotic Pathway Based on the Tumor Necrosis Factor Superfamily Member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in Breast Cancer* , 2013, The Journal of Biological Chemistry.

[26]  Dennis Shasha,et al.  miRò: a miRNA knowledge base , 2009, Database J. Biol. Databases Curation.

[27]  G. Calin,et al.  MicroRNA history: discovery, recent applications, and next frontiers. , 2011, Mutation research.

[28]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[29]  L. Pease,et al.  Gene splicing and mutagenesis by PCR-driven overlap extension , 2007, Nature Protocols.

[30]  Z. Su,et al.  Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma , 2009, Oncogene.

[31]  J. Geng,et al.  Significance of aeg‐1 expression in correlation with vegf, microvessel density and clinicopathological characteristics in triple‐negative breast cancer , 2011, Journal of surgical oncology.

[32]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[33]  Zdenko Herceg,et al.  MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells , 2013, BMC Genomics.

[34]  A. Hui,et al.  Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer , 2011, Clinical Cancer Research.

[35]  Michael Reiss,et al.  MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. , 2009, Cancer cell.

[36]  H. Allgayer,et al.  MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancer , 2012, International journal of cancer.

[37]  L. Wang,et al.  MicroRNA-mediated breast cancer metastasis: from primary site to distant organs , 2012, Oncogene.

[38]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[39]  Y. Okamoto,et al.  Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC) , 2011, Journal of Human Genetics.

[40]  R. Place,et al.  Retraction Note: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity , 2022, Oncogene.

[41]  S. Sleijfer,et al.  MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer , 2011, Breast Cancer Research and Treatment.

[42]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[43]  Libing Song,et al.  Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival , 2008, Clinical Cancer Research.

[44]  J. Zavadil,et al.  miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. , 2011, Cancer cell.

[45]  Yang Wang,et al.  MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy* , 2011, The Journal of Biological Chemistry.

[46]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[47]  Xiuping Liu,et al.  Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells , 2009, Autophagy.

[48]  F. Yu,et al.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells , 2010, Oncogene.

[49]  T. Walsh,et al.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. , 1997, British Journal of Cancer.

[50]  Derek Y. Chiang,et al.  Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. , 2009, The Journal of clinical investigation.

[51]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[52]  U. Tran,et al.  The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1 , 2009, Development.